For patients with cancer driven by alterations in genes that are beyond the reach of conventional therapies.

Aleksia combines chemistry and biology expertise to tackle hard to drug targets to impact outcomes for patients.

Learn More

If you are interested to learn more about our work or would like to speak with us about partnership opportunities, please contact us.